638 related articles for article (PubMed ID: 24819989)
1. Bile acids are nutrient signaling hormones.
Zhou H; Hylemon PB
Steroids; 2014 Aug; 86():62-8. PubMed ID: 24819989
[TBL] [Abstract][Full Text] [Related]
2. Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism.
Kwong E; Li Y; Hylemon PB; Zhou H
Acta Pharm Sin B; 2015 Mar; 5(2):151-7. PubMed ID: 26579441
[TBL] [Abstract][Full Text] [Related]
3. Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases.
Guan B; Tong J; Hao H; Yang Z; Chen K; Xu H; Wang A
Acta Pharm Sin B; 2022 May; 12(5):2129-2149. PubMed ID: 35646540
[TBL] [Abstract][Full Text] [Related]
4. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
Gillard J; Clerbaux LA; Nachit M; Sempoux C; Staels B; Bindels LB; Tailleux A; Leclercq IA
JHEP Rep; 2022 Jan; 4(1):100387. PubMed ID: 34825156
[TBL] [Abstract][Full Text] [Related]
5. Bile acid nuclear receptor FXR and digestive system diseases.
Ding L; Yang L; Wang Z; Huang W
Acta Pharm Sin B; 2015 Mar; 5(2):135-44. PubMed ID: 26579439
[TBL] [Abstract][Full Text] [Related]
6. A Current Understanding of Bile Acids in Chronic Liver Disease.
Farooqui N; Elhence A; Shalimar
J Clin Exp Hepatol; 2022; 12(1):155-173. PubMed ID: 35068796
[TBL] [Abstract][Full Text] [Related]
7. Role of farnesoid X receptor and bile acids in alcoholic liver disease.
Manley S; Ding W
Acta Pharm Sin B; 2015 Mar; 5(2):158-67. PubMed ID: 26579442
[TBL] [Abstract][Full Text] [Related]
8. Increased bile acids in enterohepatic circulation by short-term calorie restriction in male mice.
Fu ZD; Klaassen CD
Toxicol Appl Pharmacol; 2013 Dec; 273(3):680-90. PubMed ID: 24183703
[TBL] [Abstract][Full Text] [Related]
9. Disrupted coordinate regulation of farnesoid X receptor target genes in a patient with cerebrotendinous xanthomatosis.
Honda A; Salen G; Matsuzaki Y; Batta AK; Xu G; Hirayama T; Tint GS; Doy M; Shefer S
J Lipid Res; 2005 Feb; 46(2):287-96. PubMed ID: 15576845
[TBL] [Abstract][Full Text] [Related]
10. Bile acid homeostasis in female mice deficient in
Rizzolo D; Kong B; Taylor RE; Brinker A; Goedken M; Buckley B; Guo GL
Acta Pharm Sin B; 2021 Dec; 11(12):3847-3856. PubMed ID: 35024311
[TBL] [Abstract][Full Text] [Related]
11. The influences of cholecystectomy on the circadian rhythms of bile acids as well as the enterohepatic transporters and enzymes systems in mice.
Zhang F; Duan Y; Xi L; Wei M; Shi A; Zhou Y; Wei Y; Wu X
Chronobiol Int; 2018 May; 35(5):673-690. PubMed ID: 29381405
[TBL] [Abstract][Full Text] [Related]
12. Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD.
Jiao N; Baker SS; Chapa-Rodriguez A; Liu W; Nugent CA; Tsompana M; Mastrandrea L; Buck MJ; Baker RD; Genco RJ; Zhu R; Zhu L
Gut; 2018 Oct; 67(10):1881-1891. PubMed ID: 28774887
[TBL] [Abstract][Full Text] [Related]
13. Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes.
Studer E; Zhou X; Zhao R; Wang Y; Takabe K; Nagahashi M; Pandak WM; Dent P; Spiegel S; Shi R; Xu W; Liu X; Bohdan P; Zhang L; Zhou H; Hylemon PB
Hepatology; 2012 Jan; 55(1):267-76. PubMed ID: 21932398
[TBL] [Abstract][Full Text] [Related]
14. Individual bile acids have differential effects on bile acid signaling in mice.
Song P; Rockwell CE; Cui JY; Klaassen CD
Toxicol Appl Pharmacol; 2015 Feb; 283(1):57-64. PubMed ID: 25582706
[TBL] [Abstract][Full Text] [Related]
15. Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism.
Wang S; Sheng F; Zou L; Xiao J; Li P
J Adv Res; 2021 Dec; 34():109-122. PubMed ID: 35024184
[TBL] [Abstract][Full Text] [Related]
16. The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases.
Nagahashi M; Yuza K; Hirose Y; Nakajima M; Ramanathan R; Hait NC; Hylemon PB; Zhou H; Takabe K; Wakai T
J Lipid Res; 2016 Sep; 57(9):1636-43. PubMed ID: 27459945
[TBL] [Abstract][Full Text] [Related]
17. Metabolic effects of intestinal absorption and enterohepatic cycling of bile acids.
Ferrebee CB; Dawson PA
Acta Pharm Sin B; 2015 Mar; 5(2):129-34. PubMed ID: 26579438
[TBL] [Abstract][Full Text] [Related]
18. Feedback regulation of bile acid synthesis in primary human hepatocytes: evidence that CDCA is the strongest inhibitor.
Ellis E; Axelson M; Abrahamsson A; Eggertsen G; Thörne A; Nowak G; Ericzon BG; Björkhem I; Einarsson C
Hepatology; 2003 Oct; 38(4):930-8. PubMed ID: 14512880
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling.
Marchianò S; Biagioli M; Roselli R; Zampella A; Di Giorgio C; Bordoni M; Bellini R; Morretta E; Monti MC; Distrutti E; Fiorucci S
FASEB J; 2022 Jan; 36(1):e22060. PubMed ID: 34862975
[TBL] [Abstract][Full Text] [Related]
20. Addition of Dexamethasone Alters the Bile Acid Composition by Inducing CYP8B1 in Primary Cultures of Human Hepatocytes.
Mörk LM; Strom SC; Mode A; Ellis EC
J Clin Exp Hepatol; 2016 Jun; 6(2):87-93. PubMed ID: 27493455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
